Cisplatin as first-line therapy for metastatic breast cancer.
暂无分享,去创建一个
G. Sledge | L. Einhorn | B. Roth | P. Loehrer
[1] D. Schaid,et al. The effect on survival of initial chemotherapy in advanced breast cancer: polychemotherapy versus single drug. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] A. Paterson,et al. First-line mitoxantrone chemotherapy for advanced breast cancer. , 1986, Cancer treatment reports.
[3] J. Ingle,et al. A phase III clinical trial comparing the combination cyclophosphamide, adriamycin, cisplatin with cyclophosphamide, 5-fluorouracil, prednisone in patients with advanced breast cancer. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] J. Holland,et al. Chemotherapy of breast cancer , 1984, Medical oncology and tumor pharmacotherapy.
[5] R. Wittes,et al. Cisplatin in the treatment of metastatic breast carcinoma A prospective randomized trial of two dosage schedules , 1982, American journal of clinical oncology.
[6] G. Hortobagyi,et al. Phase II study of cis-dichlorodiammineplatinum(II) in advanced breast cancer. , 1978, Cancer treatment reports.
[7] Z. Mechl,et al. CAP (cyclophosphamide, adriamycin, cisplatinum) in the treatment of advanced breast cancer. , 1984, Neoplasma.